InvestorsHub Logo

gunnabeoneday

12/14/03 4:14 PM

#10304 RE: jcryan19 #10298

Jim, I couldn't agree more with your statement "I believe that DNAP is one of the most interesting stocks to own and follow. They deal with plenty of cutting edge scientific issues.."

That's why I'm invested here. I believe that DNAP is at a stage where public exposure will really start to accelerate and compliment the science, which together should bring greater interest to this little company down south. And with that interest, I believe that many investors should come to realize how undervalued we are at $26M...

This exposure could be from various issues: continued AncestryByDNA awareness, growing DNAWitness use and related press, possible OVANOME classifier being filed with FDA, adding RETINOME to DNAWitness, improved AncestryByDNA versions 2.5 and 3.0, patent related PR's, additional journal and magazine articles like the one due out in December and the one published last month in Popular Science, possible lab accreditation, possible announcement of a large customer/investor for drug discovery, additonal financing, etc, etc.

And mix in the revenue growth that we're finally seeing and DNAP is clearly taking the form of a "real" company with revenues that the average investor can associate with. Many people need to see revenue (& growth) to justify their investment. Don't forget the fact that this revenue growth will be coming from areas that will only support the larger (humongous) growth opportunities that Tony and we get real excited about!! Ovarian cancer, statins, transplants, breast cancer, and many, many other opportunities we haven't heard of yet. Not to mention their drug discovery platform and related software.

Now with funding, the extra manpower and future 2nd lab will really decrease the time to market (and time to patent application!) for additional opportunities.

Personnaly, I like the DNAP storyline, love the science and think $0.05 is a bargain given the expected exposure they should start getting.

One area that I'd appreciate some additional input on is the agreement with ORCH. Can someone explain this to me? Thanks.